Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex
Open Access
- 28 February 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (2), e17299
- https://doi.org/10.1371/journal.pone.0017299
Abstract
We present a lipidomics analysis of human Parkinson's disease tissues. We have focused on the primary visual cortex, a region that is devoid of pathological changes and Lewy bodies; and two additional regions, the amygdala and anterior cingulate cortex which contain Lewy bodies at different disease stages but do not have as severe degeneration as the substantia nigra. Using liquid chromatography mass spectrometry lipidomics techniques for an initial screen of 200 lipid species, significant changes in 79 sphingolipid, glycerophospholipid and cholesterol species were detected in the visual cortex of Parkinson's disease patients (n = 10) compared to controls (n = 10) as assessed by two-sided unpaired t-test (p-value q-value <0.05). By contrast, changes in 17 and 12 lipid species were identified in the Parkinson's disease amygdala and anterior cingulate cortex, respectively, compared to controls; none of which remained significant after false discovery rate analysis. Using gas chromatography mass spectrometry techniques, 6 out of 7 oxysterols analysed from both non-enzymatic and enzymatic pathways were also selectively increased in the Parkinson's disease visual cortex. Many of these changes in visual cortex lipids were correlated with relevant changes in the expression of genes involved in lipid metabolism and an oxidative stress response as determined by quantitative polymerase chain reaction techniques. The data indicate that changes in lipid metabolism occur in the Parkinson's disease visual cortex in the absence of obvious pathology. This suggests that normalization of lipid metabolism and/or oxidative stress status in the visual cortex may represent a novel route for treatment of non-motor symptoms, such as visual hallucinations, that are experienced by a majority of Parkinson's disease patients.Keywords
This publication has 89 references indexed in Scilit:
- Mass‐spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injuryJournal of Neurochemistry, 2010
- Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injuryBrain Research, 2010
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseBrain, 2009
- Retracted: Differential effects of 24‐hydroxycholesterol and 27‐hydroxycholesterol on tyrosine hydroxylase and α‐synuclein in human neuroblastoma SH‐SY5Y cellsJournal of Neurochemistry, 2008
- A critical evaluation of the Braak staging scheme for Parkinson's diseaseAnnals of Neurology, 2008
- Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's diseaseNature Neuroscience, 2008
- Liver X receptor β (LXRβ): A link between β-sitosterol and amyotrophic lateral sclerosis–Parkinson's dementiaProceedings of the National Academy of Sciences of the United States of America, 2008
- Statins reduce neuronal α‐synuclein aggregation in in vitro models of Parkinson’s diseaseJournal of Neurochemistry, 2008
- A Direct Approach to False Discovery RatesJournal of the Royal Statistical Society Series B: Statistical Methodology, 2002